- Home
- ONCY vs MLSS Comparison
ONCY vs MLSS Comparison
Compare ONCY & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- MLSS
- Stock Information
- Founded
- ONCY 1998
- MLSS 1989
- Country
- ONCY Canada
- MLSS United States
- Employees
- ONCY N/A
- MLSS N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- MLSS Industrial Specialties
- Sector
- ONCY Health Care
- MLSS Health Care
- Exchange
- ONCY Nasdaq
- MLSS Nasdaq
- Market Cap
- ONCY 86.1M
- MLSS 98.1M
- IPO Year
- ONCY 1999
- MLSS 1995
- Fundamental
- Price
- ONCY $0.79
- MLSS $1.18
- Analyst Decision
- ONCY Strong Buy
- MLSS Buy
- Analyst Count
- ONCY 2
- MLSS 1
- Target Price
- ONCY $4.00
- MLSS $1.25
- AVG Volume (30 Days)
- ONCY 2.4M
- MLSS 263.6K
- Earning Date
- ONCY 03-06-2025
- MLSS 11-14-2024
- Dividend Yield
- ONCY N/A
- MLSS N/A
- EPS Growth
- ONCY N/A
- MLSS N/A
- EPS
- ONCY N/A
- MLSS N/A
- Revenue
- ONCY N/A
- MLSS $8,877,010.00
- Revenue This Year
- ONCY N/A
- MLSS N/A
- Revenue Next Year
- ONCY N/A
- MLSS $17.97
- P/E Ratio
- ONCY N/A
- MLSS N/A
- Revenue Growth
- ONCY N/A
- MLSS N/A
- 52 Week Low
- ONCY $0.71
- MLSS $0.54
- 52 Week High
- ONCY $1.53
- MLSS $1.27
- Technical
- Relative Strength Index (RSI)
- ONCY 38.26
- MLSS 64.68
- Support Level
- ONCY $0.73
- MLSS $1.07
- Resistance Level
- ONCY $0.86
- MLSS $1.27
- Average True Range (ATR)
- ONCY 0.06
- MLSS 0.09
- MACD
- ONCY -0.01
- MLSS 0.02
- Stochastic Oscillator
- ONCY 20.33
- MLSS 80.85
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.